Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoproliferative Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05057494
What this trial is testing

Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
AstraZeneca 607
Testing effectiveness (Phase 2)Study completedNCT00738829
What this trial is testing

Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Arbeitsgemeinschaft medikamentoese Tumortherapie 45
Testing effectiveness (Phase 2)WithdrawnNCT00706953
What this trial is testing

Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed Multiple Myeloma Previously Treated With Bortezomib

Who this might be right for
Multiple Myeloma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Not applicableStudy completedNCT03528954
What this trial is testing

Propofol to Reduce the Incidence of Postanesthetic Emergence Agitation in Pediatric Patients Under General Anesthesia

Who this might be right for
Pediatric ALL
Universitas Indonesia 54
Testing effectiveness (Phase 2)Looking for participantsNCT07306156
What this trial is testing

GP350 CAR-T for Relapse/Refractory and Epstein-Barr Virus Infection Associated Lymphoid Neoplasms

Who this might be right for
EBV Associated Lymphoid Neoplasms
Zhimin Zhai 24
Early research (Phase 1)Study completedNCT01636622
What this trial is testing

Study of Vemurafenib, Carboplatin, and Paclitaxel

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 21
Post-approval studies (Phase 4)UnknownNCT03150602
What this trial is testing

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Who this might be right for
Peripheral T Cell LymphomaProgression, Disease
Taiwan Mundipharma Pharmaceuticals Ltd. 22
Testing effectiveness (Phase 2)UnknownNCT02248402
What this trial is testing

Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Chonnam National University Hospital 15
Testing effectiveness (Phase 2)UnknownNCT05137886
What this trial is testing

PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma, AdultRelapseRefractory Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 47
Testing effectiveness (Phase 2)Study completedNCT00924170
What this trial is testing

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

Who this might be right for
Adult T-Cell Leukemia (ATL)
National Cancer Institute (NCI) 18
Early research (Phase 1)Active Not RecruitingNCT01044069
What this trial is testing

Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

Who this might be right for
LeukemiaAcute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 93
Not applicableWithdrawnNCT02141841
What this trial is testing

Effect of Age on the Median Effective Concentration(EC50) for Motor Block With Spinal Plain Bupivacaine

Who this might be right for
Mononeuropathy of the Median Nerve, Mild
China Three Gorges University, Yichang, China
Testing effectiveness (Phase 2)Study completedNCT00596154
What this trial is testing

Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

Who this might be right for
CNS LymphomaCNS Brain CancerNon-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 33
Testing effectiveness (Phase 2)Ended earlyNCT01065805
What this trial is testing

Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Who this might be right for
Brain CancerCancerSolid Tumor+1 more
AHS Cancer Control Alberta 94
Testing effectiveness (Phase 2)Study completedNCT05844956
What this trial is testing

DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (TAI-SHAN1)

Who this might be right for
Lymphoma, Non-Hodgkin
Dizal Pharmaceuticals 17
Not applicableStudy completedNCT04364256
What this trial is testing

Muscle Stimulation for Physical Function During Stem Cell Transplant

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant
VA Office of Research and Development 46
Testing effectiveness (Phase 2)Study completedNCT00422656
What this trial is testing

Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 37
Testing effectiveness (Phase 2)Study completedNCT03364231
What this trial is testing

Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Marginal Zone LymphomaWaldenstrom MacroglobulinemiaNon Follicular Indolent Non-Hodgkin Lymphoma
TG Therapeutics, Inc. 21
Early research (Phase 1)WithdrawnNCT02875002
What this trial is testing

Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas

Who this might be right for
Relapsed and Refractory Aggressive B- and T-cell LymphomasLymphoma
Yale University
Testing effectiveness (Phase 2)UnknownNCT02836639
What this trial is testing

BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Pusan National University Hospital 20
Next Page